Skip to main content

Find Clinical Trials

Home
Conditions
Parkinson Disease

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

1,833 public trials 365 recruiting studies

Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

NCT00004826

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

NCT02092168

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: BIOTRIAL Rueil, Malmaison, France

View Trial Details

Completed

Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites

NCT01515891

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Covance Basel Research Unit AG (formerly Swiss Pharma Contract Ltd) Allschwil, Base, Switzerland

View Trial Details

Completed

A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

NCT01520727

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: BIOTRIAL Rennes, France

View Trial Details

Completed

PET Study of Non-Motor Symptoms of Parkinson Disease

NCT01565473

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: University of Michigan Health System Ann Arbor, Michigan, United States

View Trial Details

Completed

Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

NCT00467597

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: VA Medical Center, Portland Portland, Oregon, United States

View Trial Details

Completed

Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients

NCT01191944

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: 248.671.86004 Boehringer Ingelheim Investigational Site Beijing, China

248.671.86006 Boehringer Ingelheim Investigational Site Beijing, China

248.671.86007 Boehringer Ingelheim Investigational Site Beijing, China

248.671.86020 Boehringer Ingelheim Investigational Site Beijing, China

View all 20 locations

View Trial Details

Completed

Molecular Epidemiology of Parkinson's Disease

NCT00042107

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Department of Neurology, Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

NCT02248207

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

NCT02248181

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details